HUMANA INC : Regulation FD Disclosure (form 8-K)

January 08, 2020 at 05:22 pm EST

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of


                  earliest event reported): 
name="dei:DocumentPeriodEndDate" id="Fact_2ce8f89b2c164e1fb3931c14a7191254" contextRef="c20200108to20200108" format="ixt:datemonthdayyearen">January 8, 2020 (January 8, 2020)

Humana Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-05975

61-0647538

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

Latest news about Humana Inc.

Humana Keeps Quarterly Dividend at $0.885 a Share, Payable July 26 to Shareholders of Record June 28	Apr. 18	MT
Humana Inc. Declares Cash Dividend, Payable on July 26, 2024	Apr. 18	CI
Zacks Upgrades Humana to Neutral From Underperform	Apr. 17	MT
CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs	Apr. 17
Explainer-Why are US pharmacy benefit managers under fire?	Apr. 16	RE
Wall St set for higher open as upbeat earnings obscure Mideast jitters	Apr. 16	RE
Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 15	MT
Sector Update: Health Care Stocks Gain Monday Afternoon	Apr. 15	MT
Sector Update: Health Care	Apr. 15	MT
Health Care Stocks Rise After Florida's Medicaid Contract Award Announcement	Apr. 15	MT
Truist Securities Adjusts Price Target on Humana to $355 From $400	Apr. 15	MT
Wells Fargo Cuts Price Target on Humana to $350 From $413, Maintains Overweight Rating	Apr. 08	MT
S&P 500 Posts Weekly Decline on Concerns About Interest Rates	Apr. 05	MT
Goldman Sachs Cuts Price Target on Humana to $385 From $450, Maintains Buy Rating	Apr. 03	MT
Equity Markets Fall as Traders Weigh Fed Officials' Remarks	Apr. 02	MT
Sector Update: Health Care Stocks Slide Late Afternoon	Apr. 02	MT
Indexes fall as Tesla drops, rate cut timing weighed	Apr. 02	RE
Sector Update: Health Care Stocks Slipping in Afternoon Trading	Apr. 02	MT
Sector Update: Health Care	Apr. 02	MT
Surprise Gain in Job Openings, 5-Month High in Crude Oil Prices Sap Risk Appetite for US Equities	Apr. 02	MT
US Benchmark Stock Indexes Drop Following Surprise Gain in Job Openings	Apr. 02	MT
Top Midday Stories: Tesla Deliveries Disappoint Wall Street; Rivian Reaffirms Production Guidance; T. Rowe Price and BlackRock Back Disney's Directors in Proxy Battle; Healthcare Stocks Fall on Medicare Advantage Payment News; PVH Stock Plummets on Sales Guidance; BlackRock, State Street, and Vanguard in FDIC's Crosshairs; SLB to Buy CHX; US Labor Department Finalizes Tougher Rules for Retirement Fund Managers	Apr. 02	MT
UBS Cuts Humana's Price Target to $334 From $370, Maintains Neutral Rating	Apr. 02	MT
Global markets live: UBS, AT&T, Tesla, United Airlines, Humana, Wanda...	Apr. 02
Wall Street skids as yields climb on strong data	Apr. 02	RE

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Sector

Managed Healthcare

Calendar

2024-04-24 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Humana Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

324.8 USD

Average target price

390.2 USD

Spread / Average Target

+20.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

	1st Jan change	Capi.
HUMANA INC.	-29.05%	38.99B
ELEVANCE HEALTH, INC.	+11.37%	118B
CIGNA	+16.47%	98.16B
CENTENE CORPORATION	-0.62%	38.51B
MOLINA HEALTHCARE, INC.	-0.10%	21.08B
PROGYNY, INC.	-14.25%	3.15B
ALIGNMENT HEALTHCARE, INC.	-40.53%	935M
CLOVER HEALTH INVESTMENTS, CORP.	-33.71%	308M